LEBSA DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

LEBSA And Leitat Lead PHARO Pharma Water Regeneration Project

25 Sep 2024

// PRESS RELEASE

Lebsa Shareholders Meet: Tradition And Innovation To Drive Company Growth

16 Nov 2023

// PRESS RELEASE

Lebsa and Selectchemie Join Forces at CPHI Barcelona to Drive Innovation in the Pharmaceutical Industry

31 Oct 2023

// PRESS RELEASE

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

VMX

Not Confirmed

Book a meeting

envelop Contact Supplier

DIGITAL CONTENT

5 CORPORATE CONTENT #SupplierSpotlight, 17 NEWS #PharmaBuzz

media
5 CORPORATE CONTENT #SupplierSpotlight
17 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

17 All APIs, 7 CEP/COS, 1 JDMF, 4 KDMF, 17 Listed APIs

17 All APIs
7 CEP/COS
1 JDMF
4 KDMF
17 Listed APIs

KEY PRODUCTS

Amisulpride, Betahistine Dihydrochloride, Betahistine Dimesilate, Bromopride, Dequalinium Chloride, Histamine Dihydrochloride, Histamine Diphosphate Monohydrate, Lacidipine, Letermovir, Mianserin Hydrochloride, Octenidine Hydrochloride, Picloxydine Dihydrochloride, Propamidine Isetionate, Sulpiride, Tiapride Hydrochloride, Venetoclax

Amisulpride
Betahistine Dihydrochloride
Betahistine Dimesilate
Bromopride
Dequalinium Chloride
Histamine Dihydrochloride
Histamine Diphosphate Monohydrate
Lacidipine
Letermovir
Mianserin Hydrochloride
Octenidine Hydrochloride
Picloxydine Dihydrochloride
Propamidine Isetionate
Sulpiride
Tiapride Hydrochloride
Venetoclax

SERVICES

API Manufacturing, API & Drug Product Development

pharmaServices
API Manufacturing
API & Drug Product Development
- 2 API Development

INSPECTIONS & REGISTRATIONS

4 EDQM

inspections
4 EDQM

LEBSA- Your strategic API source for niche molecules.

About

Lebsa is an innovative European laboratory that specializes in the synthesis, manufacture and commercialization of APIs with a focus on niche products. With a track record spanning 70 years, Lebsa has established itself as a reputable player in the global pharmaceutical market, particularly in generic API manufacturing. Headquartered in Barcelona, Spain, Lebsa exports up to 90% of its production. Lebsa's state-of-the-art facilities, located near Barcelona, feature cutting-edge technology, equipment and automated processes. Lebsa has expertise in registering APIs in countries across Europe, Canada, Taiwan, China, Russia, Brazil and Japan.